The St. Joe Company arrives at its July 31 earnings report with its largest shareholder in active sell mode — and options traders quietly hedging more than usual.
The dominant story of the past six weeks has been persistent selling by Bruce Berkowitz and Fairholme Capital Management. Between late May and June 18, Fairholme and Berkowitz collectively disposed of roughly 535,700 shares across a series of transactions, raising approximately $34 million at prices clustering around $65. Fairholme remains the largest institutional holder by a wide margin, controlling 28.3% of outstanding shares, with Berkowitz himself separately reporting another 3.3%. The selling has not been panicked — significance scores on each trade are modest — but the consistency of the activity is hard to ignore. JOE now trades at $62.26, roughly 5% below the prices at which the bulk of those sales took place.
Short interest and borrow conditions offer no real story to tell. Shorts hold just 1.6% of the free float, and while that figure has crept up about 7.5% over the past week and 14% over the past month in share terms, the absolute level is far too low to flag as a directional signal. Borrowing costs sit at a negligible 0.52%, and availability is extraordinarily loose — more than 26 million shares remain available to borrow against roughly 911,000 currently shorted, an availability ratio above 4,300%. There is no meaningful short-side pressure building here.
Options positioning has shifted subtly but is worth noting ahead of the print. The put/call ratio has drifted to 0.187, about 1.6 standard deviations above its 20-day mean of 0.161 — not extreme by any historical measure (the 52-week high is 0.79), but the directional move over the past two weeks is clear. From late June, when the PCR touched its 52-week low of 0.12, it has climbed steadily, suggesting that some options market participants have rotated from a posture of pure call-buying toward modest downside protection. Combined with the month's 5.7% price pullback, the setup going into results looks more guarded than the low-short-interest picture alone would imply.
The Street angle is harder to assess with confidence. Valuation multiples in the dataset are anchored to stale reference points and should not be taken at face value — the PE and EV/EBITDA figures appear tied to historical periods rather than current estimates, and no recent analyst target changes are available. What the factor scores do confirm is a high dividend rank (98th percentile), suggesting the income profile remains intact, though the dividend history on file is dated to 2022 and the current payment cadence is unclear. The ORTEX short score of 33.2 is middling and has been essentially flat for two weeks, consistent with a stock where there is no strong directional conviction from the systematic signals.
Institutional ownership adds one additional layer of context. BlackRock added a modest 81,000 shares through June, and State Street and Dimensional both made small additions. The incremental buying from passive and systematic funds contrasts quietly with the active selling from Fairholme — a reminder that the concentrated holder unloading into the summer is doing so against a backdrop of steady passive inflows rather than broader institutional retreat.
The July 31 earnings print is the next thing to watch. The most recent prior report on July 22 produced a 2.6% one-day gain, but the two events before it — April 30 and a second April release — saw the stock fall 10.6% and 9.0% respectively on the day, each followed by further weakness over the following week. Whether Fairholme's continued trimming reflects views on those past prints or anticipation of what comes next is the open question the results will begin to answer.
See the live data behind this article on ORTEX.
Open JOE on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
